Scholar Rock

[Dear/Hello/Hi/Good morning/Good afternoon/Good evening/Greetings] [Dr/Doctor/Miss/Mr/Mrs/Ms] [First Name] [Last Name],

[As a follow-up from our conversation,] I’m sharing a resource that may be helpful in navigating access to ISEMBYLD™ (apitegromab-mstn). [A member of our Scholar Rock team will follow up with you to answer any questions and discuss this further.]

See Ordering and Distribution Overview here
How to order, store, and coordinate product delivery and logistics.

See Billing and Coding Guide here
Guidance on billing, coding, and claim submission, including documentation requirements for outpatient sites of care.

See Prior Authorization and Appeals Toolkit here
Step-by-step guidance to help prepare, submit, and follow up on prior authorization requests and appeals.

See Letter of Medical Necessity Template (Initiating Treatment) here
Template to help support initial coverage or prior authorization requests.

See Letter of Medical Necessity Template (Continuing Treatment) here
Template to help support reauthorization or continued coverage requests.

See Letter of Appeal Template for Healthcare Providers here
Template to help providers respond to a coverage denial and submit an appeal with supporting information.

See Letter of Appeal Template for Patients and Caregivers here
Template to help patients or caregivers provide a supporting statement describing personal experience for inclusion in a provider-submitted appeal after a denial.

If you have any questions about the information shared or need additional support, please don’t hesitate to reach out.

[Sincerely] [Best] [Regards],

[Scholar Rock Field Team Member first name and last name]

[Scholar Rock Field Team Member title]

[Scholar Rock Field Team Member phone number]

[Scholar Rock Field Team Member email address]

In accordance with applicable state law, pricing information for ISEMBYLD (apitegromab-mstn) is available here.

Visit official ISEMBYLD website for more information.

301 Binney Street, 3rd Floor
Cambridge, MA 02142

This advertisement is intended only for healthcare professionals and payers in the United States.
Reply with "unsubscribe" to be removed from future ISEMBYLD Marketing communications.